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Abstract
Background: Lifestyle modification is a cornerstone of the management of type 2 diabetes. However, in the United
Arab Emirates, a country where type 2 diabetes is highly prevalent, non-compliance with a healthy lifestyle has been
reported in many diabetic Emirati patients. The use of behavioural theories in lifestyle counselling is believed to facilitate
behavioural changes, nevertheless, there are no published data regarding the use of structured behavioural lifestyle
programmes tailored to suit Emirati culture. The primary objective of this study was to develop a behavioural lifestyle
programme and to evaluate its effectiveness in improving glycaemic control in Emirati patients with type 2 diabetes.
Methods: The Behavioural Lifestyle Intervention Study (BLIS) was a translational randomized controlled trial in which
patients (n = 35) were randomly assigned to the intervention or control group. Patients in the intervention group went
through a six-month behavioural lifestyle programme composed of 8 sessions, whereas patients in the control group
received standard care. Cognitive behavioural theory was the underpinning theory for the lifestyle intervention. HbA1c
levels were the trial’s primary outcome measure, and the main dietary factor targeted for change was carbohydrate
intake. They were measured at baseline, 3 months and 6 months and were assessed using one-way ANOVA at a
significance level of P < 0.05. All of the patients were then followed up at 1 year on all outcome measures.
Results: At 6 months, the HbA1c levels of the patients (n = 18) in the intervention group were significantly reduced
(−1.56 ± 1.81, P < 0.05), whereas no significant change was observed in the patients of the control group. Similarly, both
carbohydrate intake from cereals and total carbohydrate intake (in grams) were reduced (p < 0.05) in the intervention
group, by 32.92 ± 54.34 and 20.94 ± 56.73, respectively. At 1 year, the patients in the intervention group maintained a
significant reduction in HbA1c levels (−1.12 ± 1.46, p < 0.05), whereas no change was observed in the control group.
Conclusion: The behavioural lifestyle intervention programme was effective in improving glycaemic control
and compliance with carbohydrate intake goals in Emirati patients with type 2 diabetes. Larger randomized
controlled trials are needed to validate these results and to identify key behavioural strategies that will
improve compliance to lifestyle modifications in real life.
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Background
Type 2 diabetes is a serious growing public health
burden in the United Arab Emirates (UAE) and is
considered a major contributor to mortality and morbid-
ity rates [2]. The International Diabetes Federation (IDF)
had estimated 803,900 people living with diabetes in
UAE in 2014 and reported it one of the highest preva-
lence in the Middle East and North Africa region
(MENA) [1], highlighting the need for interventions to
manage diabetes, prevent its complications and reduce
its associated economic burden [3].
In overweight and obese patients, lifestyle modifica-
tions, including nutrition therapy, regular physical
activity and weight loss, are considered fundamental for
the management of type 2 diabetes [4]. However, com-
pliance with healthy lifestyle practices in real life has
been found to be a great challenge in Emirati patients
with type 2 diabetes [5, 6]. The use of behavioural theor-
ies as a theoretical framework for lifestyle counselling is
thought to facilitate behavioural changes [7]. A com-
monly used theory in nutrition counselling is cognitive
behavioural theory (CBT) which assumes that behav-
iours are acquired and can be modified through different
strategies [7]. Examples of these strategies include goal
setting, self-monitoring, problem solving, stimulus con-
trol, which help patients analyse and act on external and
internal cues to unhealthy dietary patterns and a seden-
tary lifestyle [7].
Large CBT lifestyle trials have shown significant results
for both the prevention of diabetes, such as the Diabetes
Prevention Program (DPP) [8], and the management of its
outcomes, such as the Look Ahead trial [9]. The signifi-
cant outcomes of these studies were said to have the
potential to direct strategies for lifestyle management of
obesity and type 2 diabetes [10]. Researchers then aimed
to investigate the reproducibility of these interventions in
real-world practice, which contrary to large controlled
trials, is subject to several limitations such as limited
resources and insufficient time.
Some of the studies aimed at translating these inter-
ventions into real-world settings yielded promising
results, particularly in reducing the incidence of type 2
diabetes and its risk factors [11–17]. However, a limited
number of studies of translational behavioural lifestyle
interventions for patients with type 2 diabetes have been
conducted and have led to mixed results [18–20]. Two
translational randomized controlled trials (RCTs) reported
significant improvement in glycaemic control in patients
with type 2 diabetes six months after a lifestyle interven-
tion programme [18, 19], whereas Welchen et al. [20] did
not show a clinically meaningful improvement in HbA1c
at 6 and 12 months after a cognitive behavioural lifestyle
treatment. Moreover, these 3 trials were conducted in
Western and Asian populations, and reports of the impact
of behavioural lifestyle programmes on outcomes in type
2 diabetes patients in the Arab Gulf region are scarce.
Replicating these programmes in Arab populations with-
out taking into consideration regional and cultural vari-
ability in dietary and physical activity patterns might be
inappropriate. Hence, our primary aim was to develop a
structured behavioural lifestyle programme tailored to suit
Emirati dietary and physical activity habits. We conducted
the programme for 6 months, and the patients were also
followed-up at 1 year. We evaluated its effectiveness in
improving HbA1c levels in patients with type 2 diabetes
as compared to standard practices. Our secondary aim
was to evaluate its effectiveness in improving associated
outcomes such as blood pressure, lipid profiles, weight
and compliance with dietary and physical activity goals.
Methods
Study design
The Behavioural Lifestyle Intervention Study (BLIS) was
a six-month randomized controlled trial with two paral-
lel arms. Randomization occurred using computer-
generated random number tables after assessments for
inclusion/exclusion criteria. The patients were assigned
to the intervention or control arm and were matched for
gender. The patients in the intervention group then
received a 6-month lifestyle programme, while the
patients in the control group received standard care.
Upon completion of the intervention, all of the patients
were followed up at 1 year.
Setting and participants
The study was conducted at Rashid Centre for Diabetes
and Research (RCDR), a tertiary care centre for diabetes
in Ajman, UAE. Patients were referred to RCDR from
primary health care centres in the Northern Emirates for
specialized diabetes care. As part of the multidisciplinary
care approach at RCRD, all of the patients were sched-
uled to meet a clinical dietitian 1–2 weeks after their
initial consultation with the endocrinologist. All patients
scheduled for the dietitian’s visit were assessed for the
eligibility criteria. If eligible, patients were then informed
about the study during their visit to the lifestyle clinic by
the research personnel. To participate in the trial, the
patients were required to meet the following inclusion
criteria: a) 18–60 years old; b) clinical diagnosis of type
2 diabetes; c) HbA1c ≥ 7 %; d) body mass index (BMI) ≥
25 (weight (Kg)/height (m2)); e) absence of a major phys-
ical disability that would restrict participation in moderate
physical activity; f ) absence of a serious heart condition,
such as heart failure, heart attack, or stroke within the last
3 months; g) absence of proliferative retinopathy or kidney
failure; and h) absence of current participation in a weight
management or lifestyle programme. Of the 55 patients
who were potentially eligible for the trial, 31 % (n = 17)
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were not eligible and 1 % (n = 3) refused to partici-
pate. Of the 35 randomized patients, 83 % completed
the trial (n = 29) (Fig. 1). All patients were recruited
between September and December 2013.
Intervention
All of the patients in the intervention group underwent a
six-month lifestyle programme composed of 8 sessions, 4
individual sessions and 4 telephone calls, which were
delivered by clinical dietitians (Fig. 2). CBT was the under-
pinning theory used to facilitate behavioural change.
Evidence-based medical nutrition therapy was followed
with all of the patients; however, the counselling method
used in the intervention group was adapted to the main
CBT strategies i.e., goal setting and self-monitoring. Goal
setting was implemented by providing the patients with a
goal chart at their baseline visit. This chart included
SMART (smart, measurable, achievable, relevant and
timed) goals for dietary changes, weight loss and physical
activity. Carbohydrate intake was the main dietary factor
targeted for change because the monitoring of carbohy-
drate intake is considered a key strategy in achieving gly-
caemic control [21]. Additionally, reducing carbohydrates
intake is arguably more relevant to the Emirati community
than reducing fat intake observed in other lifestyle inter-
ventions [10]. This is because, as observed in clinical prac-
tice, the Emirati diet is rich in carbohydrates sources such
as rice, dates and juices. The weight loss targets were indi-
vidualized based on the patients’ weight loss history and
readiness for weight loss; these targets ranged from 5-7 %.
The patients were provided with calorie-based diets
(1200–1800 kcal) to help them achieve their weight loss
targets. Physical activity targets based on the patients’
current levels of exercise were also provided. These targets
were set so that the patients would achieve a minimum of
30 minutes of moderate physical activity 5 times per week
by the end of the trial. During each individual session, the
patient’s goal charts were reviewed, and new goals were
set. Self-monitoring was encouraged through the mainten-
ance of a diet diary, which was developed and provided at
the initial assessment. In addition to individual sessions,
the patients received 4 telephone calls to their mobile
phones throughout the six-month trial. The telephone
calls were conducted in accordance with a structured
topic guide and included follow-up on the individual
SMART goals, reinforcement of the use of the diet diaries,
questions regarding the regularity of physical exercise, and
the suggestion of solutions for problems encountered as
Fig. 1 Flow diagram of subjects through the different phases of the randomized controlled trial. Computer-generated random number tables were
used for randomization after the patients were assessed with respect to the inclusion/exclusion criteria. The patients were then allocated
to the intervention or control arm and were matched for gender. The patients in the intervention group then proceeded to receive a 6-month lifestyle
programme, and the patients in the control group received standard care. Of the 55 patients who were potentially eligible for the trial, 31 % (n = 17)
were not eligible, and 1 % (n = 3) refused to participate. Of the 35 randomized patients, 83 % completed the trial (n = 29), with an attrition rate
of 17 %. The data analysis was performed in accordance with the intention-to-treat analysis protocol
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the patients attempted to adhere to a healthy lifestyle. The
intervention group also received structured educational
materials developed specifically for the Emirati commu-
nity regarding sources of carbohydrates and dietary fibre,
physical activity, eating out, and healthy cooking methods.
The patients in the control group received standard care
i.e., 3 individual sessions scheduled at baseline, 1 month
and 6 months. These patients received general dietary
guideline handouts and calorie-based diets, were provided
goals for lifestyle habits and were encouraged to employ
self-monitoring. However, the control group was not sup-
ported with goal charts, diet diaries or structured nutrition
education. All of the consultations for the intervention
were delivered within the time allocated to meet the
dietitian (Fig. 2).
Outcome measures
The trial was designed to be integrated into usual clin-
ical practice; therefore, all of the outcomes measures
were regular tests or measurements performed during
routine assessments and were abstracted from the
patients’ records. The trial’s primary outcome measure
was HbA1c level. Secondary outcomes were weight,
BMI, body composition analysis, lipid profile (serum
cholesterol, low-density lipoprotein cholesterol (LDL-C),
high-density lipoprotein cholesterol (HDL-C), and triglycer-
ides (TG)), blood pressure, carbohydrate intake in grams,
minutes of moderate physical exercise and medications for
type 2 diabetes. The HbA1c and lipid profile (LDL, HDL,
triglycerides, and total cholesterol) data were obtained
using a Roche COBAS 6000 auto analyser (Mannheim,
Germany). Systolic and diastolic blood pressures were mea-
sured in the right arm while the patient was seated and
after he/she had rested for 10 minutes. The medications
used by the patients were abstracted from their electronic
records and included all oral anti-diabetic agents as well as
insulin. Weight and height were measured using a SECA
electronic scale (Hamburg, Germany). Body composition
analysis (BCA), presented as fat mass (Kg), muscle mass
(Kg) and water mass (Kg), was based on bioelectrical
impedance using the InBody-230 analyser (Biospace,
Dogok-dong, South Korea) under standard operating
procedures. Carbohydrate intake was measured from the
patients’ three-day food records using the American Diet-
etic Association food exchange system [22]. These values
were then converted into grams of carbohydrates. The
carbohydrate exchanges included cereals, fruits, dairy prod-
ucts, vegetables, legumes and other carbohydrates. Physical
exercise, was self-reported as number of minutes per week
of physical exercise with moderate intensity and was then
Fig. 2 Design of the behavioural lifestyle intervention study (BLIS). All of the patients in the intervention group underwent a six-month lifestyle
programme composed of 8 sessions, 4 individual sessions and 4 telephone calls, which were administered by clinical dietitians. Cognitive behavioural
theory was the underpinning theory used to facilitate behavioural changes. Accordingly, strategies such as self-monitoring and goal setting were used
to improve compliance with healthy lifestyle practices. Goal setting was implemented by providing the patients with a goal chart at the baseline visit.
These charts included SMART (smart, measurable, achievable, relevant and timed) goals for carbohydrate intake, weight loss and physical
activity. During each individual session, the goal charts were reviewed and new goals were set. Self-monitoring was encouraged through
the maintenance of a diet diary, which was developed and provided at the initial assessment. The telephone calls were conducted according to a
structured topic guide. The intervention group also received structured educational materials developed specifically for the Emirati community. In all of
the patients, all of the outcome measures were assessed at baseline, 3 months and 6 months
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averaged per day. Patients were given examples of moder-
ate physical exercise commonly practiced by the Emirati
community. Metabolic measures were performed as part
of routine management in the diabetes clinic. The
anthropometric, dietary and physical activity measures
were assessed by the dietitian as part of the standard care
assessments in the lifestyle clinic. For study participants,
all of the measures were assessed at baseline, 3 months
and 6 months. All of the enrolled participants were invited
to attend a follow-up visit at 1 year.
Ethics, consent and permissions
This study was approved by the UAE Ministry of Health
research ethics committee (reference number 032013–07).
Additionally, all of the patients provided informed consent
to participate in this study.
Statistical analysis
The sample size was calculated based on the assumption of
observing a 10 % reduction in the mean HbA1c level, the
primary outcome measure, at 6 months post-intervention.
For a power of 80 %, the required sample size was
estimated to be 50 patients. The data were presented as the
mean ± standard deviation. The group means were com-
pared at baseline using Student’s t-test, and one-way
ANOVA was performed to compare the means between
the groups at different time points. Bonferroni correction
was used for all post hoc analyses to control for family-wise
error; however, if the initial ANOVA was not significant, no
further analysis was conducted. All of the tests were
performed two-sided at a significance level of P ≤ 0.05. The
data analysis was performed in accordance with the
intention-to-treat analysis protocol.
Results
The baseline characteristics of the subjects in the
intervention and control groups are presented in Table 1.
Females composed almost 65 % of the intervention and
control groups. There was no significant difference be-
tween the intervention and the control groups in HbA1c
level, the primary outcome measure, at baseline. On the
other hand, the two groups were significantly different
in systolic blood pressure (P = 0.01) and diastolic blood
pressure (p = 0.00) at baseline. Also the intervention
group had higher weight than the control group,
although non-significant (p = 0.06).
HbA1c, obesity measures and cardiovascular disease risk
(CVD) factors
Changes in HbA1c levels, weight, body composition and
CVD risk factors are shown in Table 2. HbA1c levels,
the primary outcome measure of the study, changed
significantly in the intervention group at three and six
months compared to baseline. No significant change was
observed in the control group for the same periods, as
illustrated in Fig. 3. The patients who had diabetes for
less than 5 years (n = 10) exhibited significantly greater
improvement in HbA1c levels at 3 months (−2.44 ± 1.89)
than the patients with a disease duration of more than
5 years (n = 8, −0.46 ± 0.95) (P = 0.01).The reduction in
HbA1c levels remained larger at 6 months between
those with a diabetes duration more than and less than
5 years, although the difference was not statistically sig-
nificant (−1.77 ± −0.43 vs. -0.43 ± 1.09). These findings
were not observed in the control group. Both males and
females exhibited a significant reduction in HbA1c levels
at 3 months; however, the females did not maintain the
significant change at 6 months. Additionally, for both
groups, there were no significant changes in the doses of
any of the oral anti-diabetic agents or in insulin at any
of the time points.
The mean weight of the subjects in both the interven-
tion and control groups did not change significantly at
the end of the study (P > 0.05), as shown in Table 2.
Similarly, the body composition, i.e., fat mass and
muscle mass, of the subjects did not change significantly
(P > 0.05), with the exception of water mass, which was
significantly reduced at 6-month follow-up in the con-
trol group (P = 0.03). Additionally, no significant changes
in lipid profiles or diastolic and systolic blood pressures
Table 1 Baseline patient characteristics
Interventiona Controlb P value
N (Females) 18 (12) 17 (11)
Age (Years) 38.37 ± 9.08 42.53 ± 10.9 0.87
Duration of diabetes (Years) 6.75 ± 7.59 6.8 ± 6.33 0.98
HbA1c (%) 9.39 ± 1.55 9.11 ± 1.37 0.46
Obesity measures
Weight (Kg) 94.48 ± 16.81 84.41 ± 12.7 0.06
Height (m) 1.63 ± 0.07 1.59 ± 0.087 0.11
BMI (Kg/m2) 35.87 ± 5.67 33.89 ± 6.54 0.35
Body composition
Fat mass (Kg) 41.93 ± 13.18 36.76 ± 11.29 0.23
Muscle mass (Kg) 14.04 ± 2.07 12.41 ± 1.88 0.03b
Water mass (Kg) 38.88 ± 5.67 34.24 ± 4.29 0.01b
CVD risk factors
HDL cholesterol (mmol/L) 1.05 ± 0.56 1.21 ± 0.37 0.1
LDL cholesterol (mmol/L) 3.11 ± 1.05 2.94 ± 0.77 0.86
Total cholesterol (mmol/L) 4.77 ± 1.05 4.59 ± 0.81 0.93
Triglycerides (mmol/L) 2.58 ± 1.33 2.1 ± 1.9 0.37
Systolic blood pressure ( mmHg) 136 ± 12 122 ± 14 0.01b
Diastolic blood pressure (mmHg) 76 ± 8 67 ± 9 0.00b
aContinuous data are presented as the mean ± standard deviation, and categorical
data are presented as frequencies
bSignificantly different using Student’s t-test at a significance level of P < 0.05
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were observed in the intervention and control groups at
the end of the study (P > 0.05). However, at 6 months,
41 % of the patients in the intervention group met the
American Diabetes Association targets for LDL choles-
terol (<2.6 mmol/L), compared to 24 % at baseline,
whereas only 31 % of the patients in the control group
met the targets at 6 months compared to 19 % at baseline.
Carbohydrate intake and physical exercise
Table 3 shows the patients’ carbohydrate intake (in grams)
from different sources and their physical exercise through-
out the study. At baseline, the intervention and control
groups did not differ with respect to the intake of carbo-
hydrates from all sources i.e. cereals, fruits, dairy products,
vegetables, legumes and other carbohydrates like sweets
(P > 0.05). Physical exercise was significantly higher in the
control group than the intervention group (p < 0.05), at
baseline. In the intervention group, the intake of carbohy-
drates from cereals was significantly reduced at 3 and
6 months (P < 0.01). In contrast, there was an increase in
the intake from this source in the control group at
6 months, although the increase was not statistically
significant (P > 0.05) (Fig. 4). There was a significant
reduction in the intake from dairy products in the inter-
vention group at 3 months (p < 0.05), however, the intake
increased to values close to baseline at 6 months. Simi-
larly, total carbohydrate intake decreased significantly in
the intervention group (P < 0.05) at 3 months and had
maintained its significant reduction at 6 months (P < 0.05).
There was a non-significant increase in the level of physical
exercise (min/day) in both the groups at 3 months, as
displayed in Table 3. This increase was maintained by the
intervention group at 6 months, whereas the levels had
reduced in the control group.
1 year follow-up
At the 1-year follow-up, the effect of the intervention
on HbA1c, the primary outcome, remained significant
Table 2 Changes in HbA1c (%), obesity measures and CVD risk factors at 3 months and 6 months
Intervention (n = 18)a Control (n = 17)a
3 months 6 months P valueb 3 months 6 months P valueb
HbA1c (%) (−) 1.56 ± 1.81c (−) 1.17 ± 2.11c 0.00 0.1 ± 1.37 (−)0.17 ± 1.79 0.74
Obesity measures
Weight (Kg) (−) 0.29 ± 3.12 (−) 0.72 ± 4.3 0.65 (−) 0.25 ± 1.22 (−) 0.41 ± 2.56 0.76
BMI (Kg/m2) (−) 0.01 ± 1.1 0.14 ± 1.41 0.97 (−) 0.05 ± 0.54 0.14 ± 1.44 0.97
Body composition
Fat mass (Kg) 0.00 ± 2.56 (−) 0.08 ± 3.73 0.98 (−) 1.21 ± 3.23 (−) 1.19 ± 3.91 0.26
Muscle mass (Kg) (−) 0.09 ± 0.46 (−) 0.15 ± 0.49 0.35 0.27 ± 0.93 0.17 ± 0.83 0.49
Water mass (Kg) (−) 0.14 ± 1.2 (−) 2.07 ± 7.17 0.34 0.99 ± 1.67 0.79 ± 1.36 0.03
CVD risk factors
HDL (mmol/L) 0.00 ± 0.13 (−) 0.01 ± 0.15 0.96 (−) 0.01 ± 0.17 (−) 0.01 ± 0.19 0.96
LDL (mmol/L) (−) 0.08 ± 0.89 (−) 0.09 ± 0.95 0.86 (−) 0.17 ± 0.6 (−) 0.24 ± 0.77 0.21
Total cholesterol (mmol/dL) 0.17 ± 0.69 (−) 0.13 ± 0.83 0.58 (−) 0.18 ± 0.63 (−) 0.14 ± 0.94 0.38
Triglycerides (mmol/dL) (−) 0.37 ± 1.05 (−) 0.18 ± 0.76 0.14 (−) 0.09 ± 0.4 0.12 ± 0.78 0.43
Systolic blood pressure ( mmHg) (−) 3.18 ± 11.67 (−) 1.71 ± 12.07 0.47 0.25 ± 13.16 3.13 ± 15.12 0.44
Diastolic blood pressure (mmHg) (−) 0.18 ± 8.9 0.76 ± 7.48 0.89 2.50 ± 5.35 4.19 ± 8.48 0.12
aData are presented as the mean ± standard deviation
bOne-way ANOVA was used for between-groups comparisons, with a significance level of P < 0.05
cP value < 0.0167 after Bonferroni correction
Fig. 3 Changes in HbA1c levels (%) at different time points. At
baseline, there was no significant difference in HbA1c levels, the
primary outcome measure, between the intervention and the control
groups (P > 0.05). Compared to the baseline levels, the HbA1c levels
had changed significantly in the intervention group at three months
(−1.56 ± 1.81, P < 0.05) and six months (−1.17 ± 2.11, P < 0.05), whereas
no changes in HbA1c levels were observed in the control group over
the same periods (P > 0.05). Bonferroni correction was applied during
post hoc analysis to control for family-wise error (P < 0.0167)
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(p < 0.05) with an average of 8.27 ± 1.99 % compared
to the baseline level 9.39 ± 1.55 %. In contrast, no
significant change between baseline (9.11 ± 1.37 %)
and the 1-year follow-up (8.7 ± 1.37 %) was observed
in the control group. Additionally, there were no
significant changes in the other secondary outcomes
in either the control or the intervention group, with
the exception of diastolic blood pressure, which in
the control group, was significantly higher at 1 year
(72.0 ± 8.0) compared to baseline (67.0 ± 9.0).
Discussion
The goal of this study was to develop a translational
behavioural lifestyle programme and to assess its effect-
iveness in improving glycaemic control in Emirati
patients with type 2 diabetes compared to standard care
practices. We found that the intervention effectively
achieved a significant reduction in HbA1c levels over a
period of six months, whereas no significant change was
observed in the control group during this period. The
patients in the intervention group also maintained this
reduction 1 year after completing the programme. We
also reported a significant reduction in both total carbo-
hydrate intake and carbohydrate intake from cereals over
the intervention period in the intervention group,
whereas no significant change was observed in the
control group.
Our lifestyle intervention used behavioural strategies
adapted from CBT. Strong evidence supports the use of
CBT as the underpinning theory for lifestyle counselling
with the goal of facilitating compliance with behavioural
changes [7].
In our study, the two main CBT behavioural strategies
used were SMART goal setting and self-monitoring. For
instance, all of the patients in the intervention group
received individualized SMART goals for carbohydrate
intake, which may have facilitated their compliance with
this dietary change. Additionally, the patients were
instructed to monitor their intake in food journals in an
attempt to improve their self-monitoring skills.
Behavioural strategies have been used in large lifestyle
intervention studies [8–10] that successfully achieved
significant post-intervention improvements in glycaemic
control. However, limited numbers of translational
behavioural interventions have been performed in type 2
diabetes patients. Of the few existing translational inter-
vention studies, some have shown positive impacts on
HbA1c levels at 6 months post-intervention. For instance,
Adachi et al. (2013) [18] reported a significant decrease in
HbA1c levels at the end of a 6-month behavioural lifestyle
programme (n = 91, −0.7 %, P = 0.004). Similarly, Spencer
et al. (2011) [19] reported a decrease of 0.8 % in HbA1c
levels post-intervention (n = 164, P < 0.01). However, our
results revealed slightly larger improvement in the
intervention group (−1.17 %, P < 0.01), which could be
because half of the patients in the intervention group had
diabetes for less than 5 years. However, the duration of
diabetes was not reported in the previous studies [18, 19].
Table 3 Dietary intake of carbohydrates and physical exercise at baseline, 3 months and 6 months
Intervention (n = 18)a Control (n = 17)a
Carbohydrate intake (g/day) Baseline 3 months 6 months P valueb Baseline 3 months 6 months P valueb
Cereals 172.92 ± 73.8 130.42 ± 55.12c 140.00 ± 70.17 c 0.00 149.5 ± 81.49 145.00 ± 63.56 164 ± 58.60 0.54
Fruits 15.00 ± 17.06 10.83 ± 14.37 23.33 ± 23.84 0.03 41.00 ± 28.57 37.5 ± 35.6 40.5 ± 35.05 0.91
Dairy products 10.00 ± 7.97 3.67 ± 4.67a 8.67 ± 8.54 0.00 10.00 ± 9.21 6.40 ± 6.74 8.00 ± 8.94 0.22
Vegetables 6.94 ± 3.04 6.67 ± 5.42 6.67 ± 4.20 0.96 4.67 ± 4.99 3.67 ± 2.87 7.00 ± 4.76 0.09
Legumes 3.75 ± 6.43 2.08 ± 5.02 2.08 ± 5.02 0.52 4.00 ± 8.60 1.50 ± 4.06 2.00 ± 5.01 0.38
Other carbohydrates 10.83 ± 10.09 16.67 ± 23.51 18.75 ± 23.89 0.47 7.00 ± 14.35 0.57 ± 0.95 8.00 ± 14.35 0.95
Total carbohydrates 219.44 ± 84.18 170.33 ± 75.76a 199.5 ± 86.28a 0.00 216.17 ± 89.14 202.55 ± 90.3 237.87 ± 59.42 0.3
Physical exercise (min/day) 4.67 ± 9.89 9.12 ± 17.39 12.17 ± 18.60 0.11 10.00 ± 15.99 15.19 ± 22.02 12.31 ± 13.57 0.68
aData are presented as the mean ± standard deviation
b One-way ANOVA was used for between-groups comparisons, with a significance level of P < 0.05
cP value < 0.0167 after Bonferroni correction
Fig. 4 Changes in carbohydrate intake from cereals at different time
points. *Significantly different from baseline, Bonferroni
correction (P < 0.0167)
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An association between improvements in HbA1c levels
and the duration of diabetes is well documented in the
literature. Reviews have reported that medical nutrition
therapy has the greatest effect at the initial diagnosis of
diabetes, during which a reduction in HbA1c of 1–2 units
is expected [23].
Taking into account the resource constraints encoun-
tered in clinical practice, we reduced the number of
sessions (8 sessions) included in the intervention to less
than the that of the Look Ahead trial, which consisted of
24 sessions in the first 6 months [10]. However, we
chose a session number that was greater than the smal-
lest number of sessions associated with successful
outcomes, which was 6 sessions [24]. Additionally, four
of these sessions were delivered via telephone calls.
Telephone calls have been used in many lifestyle inter-
ventions because it may reduce the strain on available
resources [24]. Telephone calls have also been observed
to have an independent positive effect on glycaemic
control in type 2 diabetes [25].
On the other hand, one could argue whether the
observed weight loss in this study was modest. Our
study primary outcome was HbA1c, hence, we chose
strategies to improve the glycemic control which are
appropriate for the Emirati community like reducing
carbohydrates intake [21] which may have negatively
affected the achievement of weight loss. Arguably, the
contribution of carbohydrates restriction to the calorie
deficit may be suggested as insufficient to achieve weight
loss compared, for instance, to reducing fat intake.
In regards to weight loss, one could argue that the
results observed in our study was modest and whether
reducing the number of sessions or restricting carbohy-
drates was insufficient to achieve . Our study primary
outcome was HbA1c, hence, we chose strategies which
were believed to improve the glycemic control and is
more appropriate to the Emirati community like restrict-
ing carbohydrates.
Another lifestyle factor that has proven challenging
to improve in real-life settings is physical exercise.
Similar to the results of Linmans et al. (2011) [13],
who reported no change in exercise levels after a life-
style intervention applied through primary care, we
did not observe a significant increase in physical exer-
cise levels over the intervention period. Similarly,
although Adachi et al. (2013) [18] reported a signifi-
cant reduction in HbA1c levels 6 months after a life-
style education programme, the observed change in
exercise status was quite modest compared to the
change in the targeted dietary habit. These findings
indicate that further investigations are needed to
identify barriers to physical activity in real life and
the key behavioural strategies that can improve com-
pliance to physical activity guidelines.
Strengths and limitations
One of the main strengths of our study was its transla-
tional design—it aimed to test a behavioural lifestyle
programme that could be incorporated into standard
care practices. Although large, controlled lifestyle trials
provide insight into what may work best under ideal sit-
uations, reproducing the same results in clinical practice
might be challenging This is because in real life, health
care professionals work under challenging conditions
that act as barriers to successful outcomes. Such barriers
include the lack of resources, limited practitioner’s time,
and demotivated patients [12]; these factors need to be
taken into consideration when designing pragmatic
trials. In BLIS, we developed a lifestyle programme based
on evidence-based behavioural theory and took into
account the feasibility of our programme in clinical
practice, both in terms of the number of sessions and
the intervention delivery method, which future research
can build upon. We also developed structured nutrition
education materials tailored to the Emirati community,
which can be used in communities with the same
cultural background.
On the other hand, one of the main limitations of our
study was its relatively small sample size despite our
efforts to recruit the calculated number of subjects. This
was mainly due to patients not coming to their initial
assessment with the dietitian for reasons like the time
gap between their first visit to the centre and the
appointment with the dietitian. Thus, future research
may need to overcome such recruitment barriers and to
investigate the effectiveness of behavioural lifestyle inter-
ventions on a larger scale, possibly utilizing a cluster-
randomized controlled design. Additionally, BLIS was
conducted in a specialized diabetes centre, and thus the
generalizability of our programme to other health care
settings, such as hospitals and primary care facilities,
remains uncertain.
Conclusion
In conclusion, this study demonstrated the effectiveness of
a translational behavioural lifestyle intervention in improv-
ing glycaemic control in Emirati patients with type 2 dia-
betes. This improvement was evident over the short term
and was maintained at 1 year post-intervention. The results
of our study add to evidence of the effectiveness of behav-
ioural lifestyle programmes in clinical practice, particularly
in the Arab region, which is an area of limited research.
More studies with larger sample size are urgently needed to
evaluate the long-term effectiveness of behavioural lifestyle
programmes. Additionally, future research might need to
evaluate the effectiveness of behavioural lifestyle interven-
tions for weight management in clinical practice and to
identify the key behavioural strategies that improve compli-
ance to healthy lifestyle practices.
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